Skip to main content
logo
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.910
-0.080 (-2.68%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Perspective Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Revenue
0.620.881.451.43--
Revenue Growth
-57.99%-39.20%1.40%---
Gross Profit
0.620.881.451.43--
Operating Income
-120.01-113.56-90.89-40.94-8.67-6.42
Net Income
-111.13-103.12-79.28-46.51-10.76-7.27
Earnings Per Share
-1.40-1.40-1.23-1.74-0.80-0.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Cash & Investments
270.93144.74226.929.2443.7655.89
Total Debt
4.233.254.062.5500.52
Net Cash (Debt)
266.7141.48222.856.6943.7655.37
Net Cash Growth
28.29%-36.51%3232.64%-84.72%-20.97%-12.19%
Net Cash Per Share
3.271.923.460.253.083.90

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jun '22 Jun '21
Operating Cash Flow
-92.37-82.48-18.29-36.91-7.71-2.84
Capital Expenditures
-14.95-12.75-54.41-1.07-0.27-0.38
Free Cash Flow
-107.32-95.23-72.71-37.99-7.98-3.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-19419.60%-12846.60%-6250.76%-2855.02%--
Pretax Margin
-18194.17%-11754.98%-5596.70%-3428.10%--
Profit Margin
-17982.70%-11665.30%-5452.48%-3243.24%--
FCF Margin
-17365.90%-10773.00%-5000.55%-2648.88%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Forward PE
-21.5121.5121.5121.5121.51
PS Ratio
537.01231.26155.0579.00--